We also evaluated the association of myalgia with MSA/MAA positivity in subjects with a lower risk of having IIM at baseline, therefore excluding those patients with typical skin rashes, increased levels of CPK and LDH, or proximal weakness. The gene discussed is PIK3C2A; the disease is Skin rash.